Asset profile
Venetoclax
Small molecule
Approvedregulatory verdict
Evidence outlook
Approved: Acute Myeloid Leukemia
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
71 competitors in this universe: 8 direct rivals (same mechanism and indication), 3 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Venetoclax: this drug | Approved | Small molecule | BCL-2 | ||
| APG-2575(Lisaftoclax ) | Phase 3 | Small molecule | BCL-2 | ||
| BGB-11417 | Phase 3 | — | BCL-2 | ||
| ICP-248 | Phase 2/3 | — | BCL-2 | ||
| FCN-338 | Phase 2 | Small molecule | BCL-2 | ||
| TGRX-814 | Phase 1/2 | — | BCL-2 | ||
| FXS0683 | Phase 1 | Biologic (subtype unspecified) | BCL-2 | ||
| Lonitoclax | Phase 1 | Small molecule | BCL-2 | ||
| ZE 50-0134 | Phase 1 | — | BCL-2 | ||
| Surzetoclax | Phase 1/2 | Small molecule | BCL-2 | ||
| BGB-21447 | Phase 1 | Small molecule | BCL-2 | ||
| LOXO-338 | Phase 1 | Small molecule | BCL-2 | ||
| ASTX727 | Approved | Small molecule | Decitabine/cedazuridine fixed combination (DNMT + CDA inhibition) | ||
| Enasidenib | Approved | Small molecule | IDH2 | ||
| Gemtuzumab Ozogamicin | Approved | Antibody–drug conjugate | CD33 | ||
| Gilteritinib | Approved | Small molecule | FLT3 |
…and 56 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(338 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (51)
October 2026 (9)
Phase 2Light Chain (AL) AmyloidosisActive not recruiting
Est. primary completion 2026-10-14 · NCT06629818 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)Recruiting
Est. primary completion 2026-10-28 · NCT05168930 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-10-30 · NCT05453903 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2026-10-30 · NCT07490288 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2026-10-31 · NCT06652685 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2026-10-31 · NCT05336812 · CT.gov ↗
What to watch
Phase 2T Acute Lymphoblastic Leukemia, T Lymphoblastic LymphomaRecruiting
Est. primary completion 2026-10-31 · NCT00501826 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-10-31 · NCT04746235 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic LeukemiaActive not recruiting
Est. primary completion 2026-10-31 · NCT06524375 · CT.gov ↗
What to watch
November 2026 (10)
Phase 1Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin LymphomaActive not recruiting
Est. primary completion 2026-11 · NCT05053659 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-11 · NCT03850574 · CT.gov ↗
What to watch
Phase 1/2Follicular LymphomaActive not recruiting
Est. primary completion 2026-11 · NCT03980171 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia (CLL)Recruiting
Est. primary completion 2026-11 · NCT04895436 · CT.gov ↗
What to watch
Phase 1/2Newly-diagnosed Ph+ Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2026-11-01 · NCT06082934 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2026-11-11 · NCT05677919 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-11-15 · NCT05226455 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic LeukemiaRecruiting
Est. primary completion 2026-11-17 · NCT03986034 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-11-19 · NCT05597306 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-11-30 · NCT06152809 · CT.gov ↗
What to watch
December 2026 (32)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT07044544 · CT.gov ↗
What to watch
Phase 1Leukemia, Myeloid Leukemia, Monocytic LeukemiaRecruiting
Est. primary completion 2026-12 · NCT06429449 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT06129734 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT06783790 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic LeukemiaActive not recruiting
Est. primary completion 2026-12 · NCT03467867 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT05955261 · CT.gov ↗
What to watch
Phase 1/2CML,Blast PhaseRecruiting
Est. primary completion 2026-12-01 · NCT06757855 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-01 · NCT05360160 · CT.gov ↗
What to watch
Phase 1/2Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Burkitt LymphomaRecruiting
Est. primary completion 2026-12-01 · NCT03223610 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-01 · NCT06635681 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-01 · NCT06220162 · CT.gov ↗
What to watch
Phase 2T-cell Acute Lymphoblastic Leukemia, RecruitingRecruiting
Est. primary completion 2026-12-01 · NCT05376111 · CT.gov ↗
What to watch
Phase 2Precursor Cell Lymphoblastic Leukemia-LymphomaRecruiting
Est. primary completion 2026-12-01 · NCT06387121 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-01 · NCT07712848 · CT.gov ↗
What to watch
Phase 1/2Hematologic MalignanciesRecruiting
Est. primary completion 2026-12-30 · NCT04588922 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-30 · NCT06284486 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-30 · NCT06451861 · CT.gov ↗
What to watch
Phase 2Ann Arbor Stage II Follicular Lymphoma, Grade 1 Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma …Recruiting
Est. primary completion 2026-12-30 · NCT06471738 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2026-12-30 · NCT07264010 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT05010772 · CT.gov ↗
What to watch
Phase 1Lymphoma, B-CellActive not recruiting
Est. primary completion 2026-12-31 · NCT04161248 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT06621212 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT05603884 · CT.gov ↗
What to watch
Phase 2Myeloproliferative NeoplasmRecruiting
Est. primary completion 2026-12-31 · NCT05074355 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT06466122 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Ibrutinib ResistanceActive not recruiting
Est. primary completion 2026-12-31 · NCT03513562 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-12-31 · NCT04128501 · CT.gov ↗
What to watch
Phase 2Blastic Plasmacytoid Dendritic Cell NeoplasmRecruiting
Est. primary completion 2026-12-31 · NCT04216524 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT03629171 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2026-12-31 · NCT07486479 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT06990321 · CT.gov ↗
What to watch
Phase 4Chronic Lymphocytic LeukemiaNot yet recruiting
Est. primary completion 2026-12-31 · NCT04790045 · CT.gov ↗
What to watch
2027 (126)
January 2027 (9)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01 · NCT05317403 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01 · NCT06773208 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-01 · NCT06384261 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-01-01 · NCT04801797 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01-16 · NCT06763341 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-01-31 · NCT03862157 · CT.gov ↗
What to watch
Phase 3Chronic Lymphocytic LeukemiaActive not recruiting
Est. primary completion 2027-01-31 · NCT03836261 · CT.gov ↗
What to watch
Phase 3Acute T Lymphoblastic Leukemia (T-ALL)Active not recruiting
Est. primary completion 2027-01-31 · NCT07541755 · CT.gov ↗
What to watch
February 2027 (10)
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-02 · NCT04086264 · CT.gov ↗
What to watch
Phase 2Chronic Lymphoid LeukemiaActive not recruiting
Est. primary completion 2027-02 · NCT04515238 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL)Active not recruiting
Est. primary completion 2027-02 · NCT03824483 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-02 · NCT05183035 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-02-01 · NCT06399640 · CT.gov ↗
What to watch
Phase 1Recurrent Plasma Cell Myeloma, Refractory Plasma Cell MyelomaActive not recruiting
Est. primary completion 2027-02-12 · NCT05391750 · CT.gov ↗
What to watch
Phase 1/2Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-02-12 · NCT04939272 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2027-02-22 · NCT05388006 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia …Active not recruiting
Est. primary completion 2027-02-28 · NCT02846623 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-02-28 · NCT06522386 · CT.gov ↗
What to watch
March 2027 (11)
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-03 · NCT05428969 · CT.gov ↗
What to watch
Phase 2Leukemia, Lymphocytic, Chronic, B-CellActive not recruiting
Est. primary completion 2027-03 · NCT05650723 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-01 · NCT06372717 · CT.gov ↗
What to watch
Phase 1/2HIV-1-infectionRecruiting
Est. primary completion 2027-03-01 · NCT05668026 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-03-02 · NCT05222984 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-08 · NCT06357182 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-03-22 · NCT03710772 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-23 · NCT05287568 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-31 · NCT04068597 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-31 · NCT06672146 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-31 · NCT05554406 · CT.gov ↗
What to watch
April 2027 (7)
Phase 1/2Multiple Myeloma, Multiple Myeloma in RelapseRecruiting
Est. primary completion 2027-04 · NCT05853965 · CT.gov ↗
What to watch
Phase 2Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma …Active not recruiting
Est. primary completion 2027-04 · NCT04450173 · CT.gov ↗
What to watch
Phase 2Early T Acute Lymphoblastic Leukemia, T-Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T/Myeloid, NosRecruiting
Est. primary completion 2027-04-01 · NCT07012447 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaEnrolling by invitation
Est. primary completion 2027-04-01 · NCT07537257 · CT.gov ↗
What to watch
Phase 1B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic LeukemiaActive not recruiting
Est. primary completion 2027-04-12 · NCT05157971 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma, Non Hodgkin Lymphoma, Hematologic MalignancyRecruiting
Est. primary completion 2027-04-28 · NCT05529069 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-04-30 · NCT03586609 · CT.gov ↗
What to watch
May 2027 (6)
Phase 1Acute Lymphoblastic LeukemiaActive not recruiting
Est. primary completion 2027-05 · NCT05386576 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)Active not recruiting
Est. primary completion 2027-05 · NCT04419519 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-05-15 · NCT04150887 · CT.gov ↗
What to watch
Phase 2Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia VariantActive not recruiting
Est. primary completion 2027-05-20 · NCT06311227 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-05-31 · NCT04975919 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic LeukemiaActive not recruiting
Est. primary completion 2027-05-31 · NCT03128879 · CT.gov ↗
What to watch
June 2027 (11)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-06 · NCT05986240 · CT.gov ↗
What to watch
Phase 2Multiple MyelomaActive not recruiting
Est. primary completion 2027-06 · NCT02899052 · CT.gov ↗
What to watch
Phase 2Marginal Zone LymphomaActive not recruiting
Est. primary completion 2027-06 · NCT04416451 · CT.gov ↗
What to watch
Phase 2B-Cell Acute Lymphoblastic Leukemia, AdultActive not recruiting
Est. primary completion 2027-06-01 · NCT07199855 · CT.gov ↗
What to watch
Phase 2Targeted Therapy, IDH1-Mutated Malignancies, MutationsRecruiting
Est. primary completion 2027-06-01 · NCT07032727 · CT.gov ↗
What to watch
Phase 1/2Mantle Cell LymphomaRecruiting
Est. primary completion 2027-06-24 · NCT03523975 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-06-30 · NCT03041688 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-06-30 · NCT04988555 · CT.gov ↗
What to watch
Phase 1/2Mantle Cell Lymphoma, Refractory LymphomaRecruiting
Est. primary completion 2027-06-30 · NCT04855695 · CT.gov ↗
What to watch
Phase 1/2Mutant IDH1 Inhibitor OlutasidenibRecruiting
Est. primary completion 2027-06-30 · NCT06445959 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-06-30 · NCT06429098 · CT.gov ↗
What to watch
July 2027 (9)
Phase 2Chronic Lymphocytic Leukemia (CLL)Active not recruiting
Est. primary completion 2027-07 · NCT04447768 · CT.gov ↗
What to watch
Phase 3Myelodysplastic Syndrome (MDS)Active not recruiting
Est. primary completion 2027-07 · NCT04401748 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-07 · NCT06090786 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-07-01 · NCT06445907 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma …Active not recruiting
Est. primary completion 2027-07-01 · NCT02756897 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-07-01 · NCT07187505 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-07-04 · NCT04227847 · CT.gov ↗
What to watch
Phase 3Mantle Cell Lymphoma (MCL)Recruiting
Est. primary completion 2027-07-10 · NCT06496308 · CT.gov ↗
What to watch
Phase 3Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2027-07-15 · NCT05057494 · CT.gov ↗
What to watch
August 2027 (10)
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-08 · NCT07214064 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08 · NCT06191263 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-08 · NCT03844048 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08-01 · NCT06532552 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-08-05 · NCT06651229 · CT.gov ↗
What to watch
Phase 2Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia …Recruiting
Est. primary completion 2027-08-10 · NCT04941716 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08-20 · NCT07183878 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08-30 · NCT07132684 · CT.gov ↗
What to watch
Phase 2T Lymphoblastic Leukemia/LymphomaRecruiting
Est. primary completion 2027-08-31 · NCT06712121 · CT.gov ↗
What to watch
Phase 2Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts …Active not recruiting
Est. primary completion 2027-08-31 · NCT05600894 · CT.gov ↗
What to watch
September 2027 (10)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09 · NCT07451912 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-09 · NCT07726576 · CT.gov ↗
What to watch
Phase 1/2AL AmyloidosisActive not recruiting
Est. primary completion 2027-09 · NCT05451771 · CT.gov ↗
What to watch
Phase 3Chronic Lymphoid LeukemiaActive not recruiting
Est. primary completion 2027-09 · NCT04608318 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-01 · NCT07743112 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-09-30 · NCT07722767 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT03471260 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT03214562 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT05401097 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT07514936 · CT.gov ↗
What to watch
October 2027 (8)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10 · NCT06634394 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-10 · NCT07486726 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10 · NCT06511882 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10-01 · NCT07374029 · CT.gov ↗
What to watch
Early phase / not applicableMyeloid TumorsNot yet recruiting
Est. primary completion 2027-10-01 · NCT07632170 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10-11 · NCT06504459 · CT.gov ↗
What to watch
Phase 2T-cell Acute Lymphoblastic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, RelapseRecruiting
Est. primary completion 2027-10-30 · NCT06686108 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-10-31 · NCT02250937 · CT.gov ↗
What to watch
November 2027 (6)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11 · NCT06660368 · CT.gov ↗
What to watch
Phase 4Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11 · NCT07044687 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11-01 · NCT04256317 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11-25 · NCT06917911 · CT.gov ↗
What to watch
Phase 1/2Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small LymphocyticActive not recruiting
Est. primary completion 2027-11-26 · NCT03331198 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11-29 · NCT04774393 · CT.gov ↗
What to watch
December 2027 (29)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12 · NCT04581512 · CT.gov ↗
What to watch
Phase 1/2Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome …Active not recruiting
Est. primary completion 2027-12 · NCT04623541 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-12 · NCT06470841 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12 · NCT02781883 · CT.gov ↗
What to watch
Phase 2T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, Mixed Phenotype Acute LeukemiaRecruiting
Est. primary completion 2027-12 · NCT06390319 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12 · NCT07255872 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-01 · NCT06548230 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-12-01 · NCT06744556 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)Recruiting
Est. primary completion 2027-12-01 · NCT06958705 · CT.gov ↗
What to watch
Phase 1B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Mixed Phenotype Acute Leukemia …Active not recruiting
Est. primary completion 2027-12-02 · NCT04872790 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-12-10 · NCT03844815 · CT.gov ↗
What to watch
Phase 2Precursor Cell Lymphoblastic Leukemia-LymphomaRecruiting
Est. primary completion 2027-12-15 · NCT05660473 · CT.gov ↗
What to watch
Phase 2Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2027-12-15 · NCT05963074 · CT.gov ↗
What to watch
Phase 4Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-30 · NCT06571825 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-30 · NCT06232694 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-30 · NCT06386302 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-30 · NCT06328179 · CT.gov ↗
What to watch
Phase 1Refractory Acute Leukemia, Relapsed Acute Leukemia, Undifferentiated Leukemia, Bi-Phenotypic LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT06466395 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07828535 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT03874052 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT04797767 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT06621199 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07748455 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07557056 · CT.gov ↗
What to watch
Phase 2Myelodysplastic Syndromes, Myeloproliferative Chronic Myelomonocytic LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT05365035 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2027-12-31 · NCT07734038 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT05554393 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT04708054 · CT.gov ↗
What to watch
Phase 2/3Older Patients, Myeloid Malignancies, Conditioning, Hematopoietic Stem Cell Transplantation (HSCT)Not yet recruiting
Est. primary completion 2027-12-31 · NCT07052422 · CT.gov ↗
What to watch
2028 (79)
January 2028 (6)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01 · NCT07392242 · CT.gov ↗
What to watch
Phase 1B-cell Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2028-01-01 · NCT06863259 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01-01 · NCT03661307 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01-01 · NCT07243483 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01-30 · NCT05010122 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01-30 · NCT06265545 · CT.gov ↗
What to watch
February 2028 (5)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-02-01 · NCT07439211 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-02-01 · NCT07407660 · CT.gov ↗
What to watch
Phase 2Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, CD5 Positive, FCER2 Negative …Active not recruiting
Est. primary completion 2028-02-08 · NCT03946878 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-02-09 · NCT06456463 · CT.gov ↗
What to watch
Phase 2Myelodysplastic Syndromes, Leukemia, Myelomonocytic, ChronicActive not recruiting
Est. primary completion 2028-02-14 · NCT05201066 · CT.gov ↗
What to watch
March 2028 (11)
Phase 2Waldenstrom Macroglobulinemia, Treatment NaiveRecruiting
Est. primary completion 2028-03 · NCT05099471 · CT.gov ↗
What to watch
Phase 3Chronic Lymphocytic LeukemiaRecruiting
Est. primary completion 2028-03 · NCT06428019 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2028-03-01 · NCT04560322 · CT.gov ↗
What to watch
Early phase / not applicableAcute Lymphoblastic Leukemia, AdultRecruiting
Est. primary completion 2028-03-01 · NCT07495631 · CT.gov ↗
What to watch
Early phase / not applicablePh-Like, Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2028-03-01 · NCT07454226 · CT.gov ↗
What to watch
Phase 2Relapsed and Refractory Multiple MyelomaRecruiting
Est. primary completion 2028-03-26 · NCT05530421 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-03-31 · NCT07507825 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-03-31 · NCT07783100 · CT.gov ↗
What to watch
Phase 2Lymphoplasmacytic Lymphoma, Waldenstrom MacroglobulinemiaRecruiting
Est. primary completion 2028-03-31 · NCT04840602 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-03-31 · NCT07469046 · CT.gov ↗
What to watch
Early phase / not applicablePh+ ALLRecruiting
Est. primary completion 2028-03-31 · NCT07493161 · CT.gov ↗
What to watch
April 2028 (4)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-04-01 · NCT07514832 · CT.gov ↗
What to watch
Phase 2/3Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma …Active not recruiting
Est. primary completion 2028-04-01 · NCT03984448 · CT.gov ↗
What to watch
Phase 2Waldenstrom Macroglobulinemia, Lymphoplasmacytic LymphomaRecruiting
Est. primary completion 2028-04-11 · NCT07231952 · CT.gov ↗
What to watch
May 2028 (8)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-05 · NCT07283094 · CT.gov ↗
What to watch
Phase 2Lymphoma, Mantle-CellRecruiting
Est. primary completion 2028-05 · NCT06558604 · CT.gov ↗
What to watch
Phase 3Chronic Lymphocytic LeukemiaRecruiting
Est. primary completion 2028-05 · NCT05197192 · CT.gov ↗
What to watch
Phase 3Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2028-05-07 · NCT03701282 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2028-05-10 · NCT07131059 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-05-15 · NCT06954987 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-05-31 · NCT07664839 · CT.gov ↗
What to watch
Phase 2Ph- Acute Lymphoblastic Leukemia (Ph-ALL)Not yet recruiting
Est. primary completion 2028-05-31 · NCT07643103 · CT.gov ↗
What to watch
June 2028 (8)
Phase 1Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-06 · NCT07814339 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-06 · NCT06668558 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-06 · NCT05404906 · CT.gov ↗
What to watch
Phase 1Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2028-06-01 · NCT07133997 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-06-01 · NCT07642453 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL VariantRecruiting
Est. primary completion 2028-06-05 · NCT07014917 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-06-30 · NCT05834244 · CT.gov ↗
What to watch
Phase 1Recurrent AL Amyloidosis, Refractory AL AmyloidosisActive not recruiting
Est. primary completion 2028-06-30 · NCT04847453 · CT.gov ↗
What to watch
July 2028 (8)
Phase 2Waldenstrom Macroglobulinemia, Lymphoplasmacytic LymphomaActive not recruiting
Est. primary completion 2028-07 · NCT07387471 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-07 · NCT07605949 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-07-02 · NCT05292664 · CT.gov ↗
What to watch
Phase 3CancerActive not recruiting
Est. primary completion 2028-07-05 · NCT03768063 · CT.gov ↗
What to watch
Phase 2Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia …Recruiting
Est. primary completion 2028-07-09 · NCT04169737 · CT.gov ↗
What to watch
Phase 1/2Chronic Myelomonocytic Leukemia, Myelodysplastic SyndromeActive not recruiting
Est. primary completion 2028-07-20 · NCT04655755 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-07-20 · NCT07735117 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-07-31 · NCT05520567 · CT.gov ↗
What to watch
September 2028 (5)
Phase 1Myeloproliferative NeoplasmNot yet recruiting
Est. primary completion 2028-09-01 · NCT07679334 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-09-01 · NCT04140487 · CT.gov ↗
What to watch
Phase 2Adult T-cell Leukemia/LymphomaRecruiting
Est. primary completion 2028-09-01 · NCT07159620 · CT.gov ↗
What to watch
Phase 2High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma …Recruiting
Est. primary completion 2028-09-01 · NCT06649812 · CT.gov ↗
What to watch
Phase 2Acute Monocytic LeukemiaRecruiting
Est. primary completion 2028-09-30 · NCT07512700 · CT.gov ↗
What to watch
October 2028 (7)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-10 · NCT07059975 · CT.gov ↗
What to watch
Phase 2Lymphoma, Marginal Zone Lymphoma, MZLRecruiting
Est. primary completion 2028-10 · NCT06510309 · CT.gov ↗
What to watch
Phase 1/2Leukemia, Relapsed Leukemia, Chronic Lymphocytic Leukemia, Relapsed Cancer, Refractory LeukemiaRecruiting
Est. primary completion 2028-10-01 · NCT06644183 · CT.gov ↗
What to watch
Phase 2Diffuse Large B Cell LymphomaNot yet recruiting
Est. primary completion 2028-10-01 · NCT06516978 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-10-01 · NCT07425808 · CT.gov ↗
What to watch
Phase 3Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2028-10-01 · NCT04269902 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma (MCL)Active not recruiting
Est. primary completion 2028-10-31 · NCT05951959 · CT.gov ↗
What to watch
November 2028 (2)
December 2028 (15)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12 · NCT05342584 · CT.gov ↗
What to watch
Phase 1Kidney Failure Chronic, Stem Cell Transplant, Stem Cell Transplant Complications, Tolerance, Hematologic CancerNot yet recruiting
Est. primary completion 2028-12 · NCT07358195 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12 · NCT06221683 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-12 · NCT07060001 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12 · NCT06014489 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12 · NCT07075016 · CT.gov ↗
What to watch
Phase 2Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Recruiting
Est. primary completion 2028-12-10 · NCT07007052 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-12-15 · NCT06841952 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT06448013 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT07177079 · CT.gov ↗
What to watch
Phase 1Refractory Acute Leukemia, Pediatric RelapsedRecruiting
Est. primary completion 2028-12-31 · NCT06397027 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT06191978 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT07148180 · CT.gov ↗
What to watch
Phase 2Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT06317662 · CT.gov ↗
What to watch
2029 (38)
January 2029 (4)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-01-25 · NCT05263284 · CT.gov ↗
What to watch
Phase 2Waldenstrom MacroglobulinemiaActive not recruiting
Est. primary completion 2029-01-25 · NCT05734495 · CT.gov ↗
What to watch
Phase 1/2T-cell Prolymphocytic Leukemia, Refractory T-Cell Prolymphocytic LeukemiaRecruiting
Est. primary completion 2029-01-31 · NCT07311746 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-01-31 · NCT06084819 · CT.gov ↗
What to watch
February 2029 (2)
March 2029 (3)
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-03 · NCT04628026 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-03-31 · NCT06782542 · CT.gov ↗
What to watch
April 2029 (3)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-04 · NCT06696183 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Small Lymphocytic LymphomaNot yet recruiting
Est. primary completion 2029-04-14 · NCT07582159 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-04-30 · NCT05807932 · CT.gov ↗
What to watch
May 2029 (5)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-05 · NCT07023588 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)Recruiting
Est. primary completion 2029-05-01 · NCT07024706 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-05-15 · NCT06317649 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-05-15 · NCT05564390 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-05-31 · NCT07635485 · CT.gov ↗
What to watch
June 2029 (5)
Phase 1Acute Myeloid LeukemiaEnrolling by invitation
Est. primary completion 2029-06 · NCT07014462 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2029-06-08 · NCT07218510 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-06-22 · NCT06852222 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-06-24 · NCT07228273 · CT.gov ↗
What to watch
Phase 2Myelodysplastic Neoplasms, TransplantationRecruiting
Est. primary completion 2029-06-30 · NCT07047183 · CT.gov ↗
What to watch
July 2029 (4)
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-07 · NCT07762508 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma (MCL)Recruiting
Est. primary completion 2029-07-01 · NCT07719556 · CT.gov ↗
What to watch
Early phase / not applicableChronic Lymphoid LeukemiaNot yet recruiting
Est. primary completion 2029-07-31 · NCT07691047 · CT.gov ↗
What to watch
August 2029 (1)
Phase 1Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-08-01 · NCT07511062 · CT.gov ↗
What to watch
September 2029 (2)
October 2029 (1)
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-10-01 · NCT07755202 · CT.gov ↗
What to watch
December 2029 (8)
Phase 2Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecruiting
Est. primary completion 2029-12 · NCT07154264 · CT.gov ↗
What to watch
Phase 2LALNot yet recruiting
Est. primary completion 2029-12-01 · NCT07522801 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic LeukemiaNot yet recruiting
Est. primary completion 2029-12-01 · NCT07690891 · CT.gov ↗
What to watch
Phase 2Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell LymphomaRecruiting
Est. primary completion 2029-12-30 · NCT05910801 · CT.gov ↗
What to watch
Phase 1T-cell Acute Lymphoblastic Leukemia, LymphomaRecruiting
Est. primary completion 2029-12-31 · NCT07513129 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaNot yet recruiting
Est. primary completion 2029-12-31 · NCT07738887 · CT.gov ↗
What to watch
Phase 2T-cell Acute Lymphoblastic Leukemia, T-Cell Lymphoblastic LymphomaRecruiting
Est. primary completion 2029-12-31 · NCT06561074 · CT.gov ↗
What to watch
Phase 2/3Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)Recruiting
Est. primary completion 2029-12-31 · NCT06764238 · CT.gov ↗
What to watch
2030 (24)
January 2030 (2)
Phase 3Venentoclax, Myeloid Malignancies, Conditioning, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leucemia …Recruiting
Est. primary completion 2030-01-31 · NCT07396480 · CT.gov ↗
What to watch
March 2030 (1)
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-03-31 · NCT06972641 · CT.gov ↗
What to watch
April 2030 (5)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-04 · NCT05735184 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-04 · NCT07478991 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-04-01 · NCT07539818 · CT.gov ↗
What to watch
Early phase / not applicableAdult ALL, MPALNot yet recruiting
Est. primary completion 2030-04-01 · NCT06991920 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-04-26 · NCT07153497 · CT.gov ↗
What to watch
May 2030 (1)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-05-31 · NCT02115295 · CT.gov ↗
What to watch
June 2030 (7)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-06 · NCT07078591 · CT.gov ↗
What to watch
Phase 2Myelodysplastic SyndromesRecruiting
Est. primary completion 2030-06 · NCT07238686 · CT.gov ↗
What to watch
Phase 2/3Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic LymphomaRecruiting
Est. primary completion 2030-06 · NCT06855810 · CT.gov ↗
What to watch
Phase 1/2T-cell-prolymphocytic Leukemia, Cutaneous T-Cell Lymphoma RefractoryRecruiting
Est. primary completion 2030-06-01 · NCT06810778 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-06-01 · NCT07672262 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-06-17 · NCT07320235 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2030-06-30 · NCT06520098 · CT.gov ↗
What to watch
July 2030 (1)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-07-21 · NCT05442216 · CT.gov ↗
What to watch
August 2030 (1)
Phase 1Small Cell Lung Cancer ( SCLC ), Neuroendocrine Cancer, Malignant Pleural Mesotheliomas (Mpm), Synovial SarcomasRecruiting
Est. primary completion 2030-08-29 · NCT07713732 · CT.gov ↗
What to watch
September 2030 (3)
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-09 · NCT06598384 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-09 · NCT05904106 · CT.gov ↗
What to watch
Phase 3Leukemia, B-Cell, Chronic, LeukemiaNot yet recruiting
Est. primary completion 2030-09 · NCT07082452 · CT.gov ↗
What to watch
October 2030 (1)
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2030-10-31 · NCT04062266 · CT.gov ↗
What to watch
December 2030 (2)
2031 (10)
February 2031 (1)
Phase 1Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRecruiting
Est. primary completion 2031-02-10 · NCT05091424 · CT.gov ↗
What to watch
March 2031 (1)
Phase 1Hematologic CancerActive not recruiting
Est. primary completion 2031-03 · NCT05753501 · CT.gov ↗
What to watch
May 2031 (2)
June 2031 (2)
September 2031 (2)
October 2031 (1)
Phase 1/2Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent …Not yet recruiting
Est. primary completion 2031-10-01 · NCT07175415 · CT.gov ↗
What to watch
November 2031 (1)
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2031-11 · NCT07007312 · CT.gov ↗
What to watch
2032 (6)
February 2032 (2)
Phase 1/2Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent …Recruiting
Est. primary completion 2032-02-01 · NCT05745714 · CT.gov ↗
What to watch
Phase 1/2Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent …Recruiting
Est. primary completion 2032-02-01 · NCT05751044 · CT.gov ↗
What to watch
March 2032 (1)
Phase 1/2Leukemia, LymphomaRecruiting
Est. primary completion 2032-03 · NCT07294677 · CT.gov ↗
What to watch
June 2032 (2)
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2032-06 · NCT07581002 · CT.gov ↗
What to watch
Phase 3Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma, Lymphoma, Small Lymphocytic, CLL, SLLRecruiting
Est. primary completion 2032-06-01 · NCT05947851 · CT.gov ↗
What to watch
December 2032 (1)
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2032-12 · NCT03013998 · CT.gov ↗
What to watch
2033 (1)
May 2033 (1)
Phase 1/2B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2033-05 · NCT07520006 · CT.gov ↗
What to watch
2034 (1)
September 2034 (1)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2034-09-22 · NCT07437950 · CT.gov ↗
What to watch
2038 (1)
December 2038 (1)
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2038-12-31 · NCT05725200 · CT.gov ↗
What to watch
2040 (1)
December 2040 (1)
Phase 2Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive …Active not recruiting
Est. primary completion 2040-12-31 · NCT02689440 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.